Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
No therapeutic, diagnostic, or clinical claims are made or implied
Metabolic shifts, such as in glucose handling, must be monitored in at-risk men
Inspection Before Use Before using any vial, visually inspect for: Cloudiness or discoloration (solution should be clear and colorless) Visible particles or precipitate Cracks, leaks, or damage to the vial or septum Any sign of contamination or compromise Do not use vials that show any sign of contamination or damage
The recommended daily dosage should not be exceeded
TISSUE HEALING & REGENERATION